RxDoctor Payments Data

Phillip Yuan, MD

Orthopedic Surgery · Long Beach, CANPI 1821077595

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (47.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 36 manufacturers reported payments, led by Choice Spine, LLC at 32.7% of the total. Among orthopedic surgery clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$59,991in general payments, 2019–2025

Across 281 payments — averaging $213.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Choice Spine, LLC$20K
  • Kuros Biosciences USA, Inc$11K
  • Globus Medical$6K
  • Kyocera Medical Technologies, Inc.$5K
  • Medtronic$3K
  • Johnson & Johnson$2K
  • plus $12K from 30 others
$250,161in research payments, 2019–2025

Across 63 payments — averaging $3970.82 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$107K
  • Prosidyan, Inc$55K
  • Mesoblast, Inc.$55K
  • Si-bone, Inc.$16K
  • Depuy Synthes Products, Inc.$11K
  • Relievant Medsystems, Inc.$7K

What the payments were for

  • Consulting fees$28,70048%
  • Speaking & faculty fees$2,5004%
  • Travel & lodging$12,63921%
  • Food & beverage$16,12827%
  • Entertainment$240%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$59,991 in reported general payments places this provider in the 90th percentile of 130 orthopedic surgery providers in California.

See all orthopedic surgery providers in California

Medicare billing

Part B allowed, 2024
$451,894
Medicare patients
567
Services billed
2,826

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen68$702
Gabapentin93$587
Methylprednisolone28$239
Cyclobenzaprine Hcl38$235
Tramadol Hcl29$118
Meloxicam11$28
Diazepam21$19

Paid to pharmacies, not to this prescriber.

Other orthopedic surgery in Long Beach

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →